thomasdevos
10-05-2009, 10:59 PM
Prostate Cancer Therapy ? Active Hexose Correlated Compound (AHCC) ? Part 1
The severity of prostate cancer has led medical experts and scientists around the world to come with all sorts of medicines, cures, treatments, therapies, etc. This article looks closely at one of them ? AHCC for give you a better understanding and to see if it really works or not in treating the type of prostate cancer and / or other forms of cancer.
As I said, there are many existing treatments for prostate cancer, and the most interesting thing about them is that they all apply best when the disease is in its infancy. For this reason, many patients actually already aware of this are flummoxed when they are told that the disease they are suffering from cancer is one that has metastasized to regions of the body beyond the prostate.
Although the majority of cancer research at this time are focused on finding ways to prevent disease entirely and provide definitive treatment of the condition, many of them have also focused on drugs that will help improve the curability of prostate cancer accurately when it has advanced prostate cancer.
AHCC (Active Hexose-Correlated Compound) is a supplement mushroom extract with known health benefits, may be some side effects, and certainly some risks that are undocumented. In recent clinical trials, it has been found to have great potential with the immune system and liver health, while also acting as a modifier of biological response.
The tests were focused on the belief that the compound in May increased activity of natural killer cells, macrophage activity increase, enhance cytokine production, and support liver function, while also playing a anti-oxidant and ? AHCC has survived.
Reference Site:
prostate cancer treatment (http://prostate-cancer-treatment-cure.com)
prostatecancerfoundation (http://www.prostatecancerfoundation.org)
en.wikipedia.org (http://en.wikipedia.org/wiki/Prostate_cancer)
www.cancer.gov (http://www.cancer.gov/cancertopics/types/prostate)
neworiental (http://www.neworiental.org/publish/portal0/tab1127/info377702.htm)
The severity of prostate cancer has led medical experts and scientists around the world to come with all sorts of medicines, cures, treatments, therapies, etc. This article looks closely at one of them ? AHCC for give you a better understanding and to see if it really works or not in treating the type of prostate cancer and / or other forms of cancer.
As I said, there are many existing treatments for prostate cancer, and the most interesting thing about them is that they all apply best when the disease is in its infancy. For this reason, many patients actually already aware of this are flummoxed when they are told that the disease they are suffering from cancer is one that has metastasized to regions of the body beyond the prostate.
Although the majority of cancer research at this time are focused on finding ways to prevent disease entirely and provide definitive treatment of the condition, many of them have also focused on drugs that will help improve the curability of prostate cancer accurately when it has advanced prostate cancer.
AHCC (Active Hexose-Correlated Compound) is a supplement mushroom extract with known health benefits, may be some side effects, and certainly some risks that are undocumented. In recent clinical trials, it has been found to have great potential with the immune system and liver health, while also acting as a modifier of biological response.
The tests were focused on the belief that the compound in May increased activity of natural killer cells, macrophage activity increase, enhance cytokine production, and support liver function, while also playing a anti-oxidant and ? AHCC has survived.
Reference Site:
prostate cancer treatment (http://prostate-cancer-treatment-cure.com)
prostatecancerfoundation (http://www.prostatecancerfoundation.org)
en.wikipedia.org (http://en.wikipedia.org/wiki/Prostate_cancer)
www.cancer.gov (http://www.cancer.gov/cancertopics/types/prostate)
neworiental (http://www.neworiental.org/publish/portal0/tab1127/info377702.htm)